MGUS Patients Have More Frequent Hospital Visits Prior to Diagnosis than Healthy Controls, Research Shows
People with monoclonal gammopathy of undetermined significance (MGUS),…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read morePeople with monoclonal gammopathy of undetermined significance (MGUS),…
Janssen’s investigational CAR T-cell therapy for multiple myeloma,…
A combination of Kyprolis (carfilzomib), Revlimid…
Early treatment with a triple combination therapy containing…
Adding the antibody Darzalex (daratumumab) to…
Venclexta (venetoclax), approved to treat lymphoma and leukemia, may…